Medical Oncologists' Knowledge and Perspectives on the Use of Biosimilars in the United States.

In this sample of medical oncologists, knowledge about basic features of biosimilars was limited and access to information about biosimilars was insufficient. The present study determined that educational programs on biosimilars for oncologists are needed and identified priorities for such efforts.